Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements ; volume:17 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-9 ; date:12.2024
Thyroid research ; 17, Heft 1 (16.9.2024), 1-9, 12.2024
- Urheber
-
Uno, Daisuke
Endo, Kazuhira
Yoshikawa, Tomomi
Hirai, Nobuyuki
Kobayashi, Eiji
Nakanishi, Yosuke
Kondo, Satoru
Yoshizaki, Tomokazu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13044-024-00209-4
- URN
-
urn:nbn:de:101:1-2411010803067.187972714458
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Uno, Daisuke
- Endo, Kazuhira
- Yoshikawa, Tomomi
- Hirai, Nobuyuki
- Kobayashi, Eiji
- Nakanishi, Yosuke
- Kondo, Satoru
- Yoshizaki, Tomokazu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
Functional characterization of BRAF mutations in multiple myeloma
Functional characterizations of BRAF mutations in multiple myeloma
Clinical significance of BRAF mutations in metastatic melanoma
Targeted Therapy for Melanomas Without BRAF V600 Mutations
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
BRAF mutations in thyroid tumors from an ethnically diverse group
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations
Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
Functional characterization of BRAF mutations in multiple myeloma
Functional characterizations of BRAF mutations in multiple myeloma
Clinical significance of BRAF mutations in metastatic melanoma
Targeted Therapy for Melanomas Without BRAF V600 Mutations
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
BRAF mutations in thyroid tumors from an ethnically diverse group
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
Functional characterization of cancer- and RASopathies-associated SHP2 and BRAF mutations
Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
Functional characterization of BRAF mutations in multiple myeloma
Functional characterizations of BRAF mutations in multiple myeloma
Clinical significance of BRAF mutations in metastatic melanoma
Targeted Therapy for Melanomas Without BRAF V600 Mutations
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
BRAF mutations in thyroid tumors from an ethnically diverse group
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms